STELLA, LEONARDO
 Distribuzione geografica
Continente #
AS - Asia 107
AF - Africa 34
EU - Europa 33
NA - Nord America 22
SA - Sud America 2
Totale 198
Nazione #
SG - Singapore 55
EG - Egitto 33
VN - Vietnam 29
IT - Italia 22
US - Stati Uniti d'America 19
JP - Giappone 10
GB - Regno Unito 6
IN - India 6
MX - Messico 3
BR - Brasile 2
FR - Francia 2
HK - Hong Kong 2
NL - Olanda 2
CN - Cina 1
DZ - Algeria 1
ID - Indonesia 1
KG - Kirghizistan 1
KR - Corea 1
PK - Pakistan 1
RO - Romania 1
Totale 198
Città #
Al Mansurah 20
Singapore 12
Cairo 11
Ho Chi Minh City 10
Tokyo 9
Boardman 6
Rome 6
Hanoi 5
Los Angeles 5
Verona 5
Ashburn 3
Phủ Lý 3
Bologna 2
Hong Kong 2
Mexico City 2
Milan 2
Naples 2
Oakland 2
Portsmouth 2
Aga 1
Ahmedabad 1
Banjar Badung 1
Bishkek 1
Bắc Giang 1
Bắc Ninh 1
Chandigarh 1
Chennai 1
Council Bluffs 1
Cubatão 1
Da Nang 1
Danbury 1
Dikirnis 1
Faisalabad 1
Fukuoka 1
Guarujá 1
Indore 1
Kolkata 1
Mapo-gu 1
Morelia 1
Nam Định 1
Nha Trang 1
Palermo 1
Phú Thọ 1
Quảng Nam Province 1
Quảng Ngãi 1
The Bronx 1
Thái Bình 1
Valenton 1
Totale 138
Nome #
PO5-12-YI Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab-Bevacizumab for hepatocellular carcinoma 31
PP0819 HEPATITIS C TREATMENT IMPROVES ONCOLOGIC OUTCOMES IN PATIENTS RECEIVING ATEZOLIZUMAB PLUS BEVACIZUMAB 24
PO4-03-YI Efficacy and safety of atezoliumab/bevacizumab for hepatocellular carcinoma in a real-world prospective cohort: a 2024 update 19
PO6-11 Statins in patients with advanced HCC treated with atezolizumab/bevacizumab: a propensity score-matched cohort analysis from ARTE an Italian prospective multicentric dataset 17
PO5-18-YI Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma 11
PO3-23-YI The changing epidemiology of patients with HCC receiving a first-line systemic therapy: insights from ARPES and ARTE databases (2008- 2024) 10
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 7
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 7
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 6
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 5
Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma 5
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results 4
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 4
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 4
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 4
THU-492 Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 4
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment 4
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 4
COVID-19 and intestinal inflammation: Role of fecal calprotectin 4
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 4
Malnutrition in COVID-19 survivors: prevalence and risk factors 4
Assessment of neurological manifestations in hospitalized patients with COVID‐19 4
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive 3
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease 3
Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice 3
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection 3
COVID-19 atypical Parsonage-Turner syndrome: a case report 3
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 3
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 3
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 3
Manuale di malattie infettive e microbiologia. Concorso Nazionale SSM 3
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 3
Liver cirrhosis in the Emergency Department: a change of paradigm in DAAs era 3
Intestinal Inflammation and Permeability in Patients Recovered from SARS-CoV-2 Infection 3
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 3
The diagnosis of neglected tropical diseases (NTDs) in Italy: reply 2
Neuropsychological Measures of Long COVID-19 Fog in Older Subjects 2
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings 2
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 2
Persistent Symptoms in Patients After Acute COVID-19 2
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 2
OC.03.3 COMPARATIVE ANALYSIS OF ATEZOBEV’S THERAPEUTIC EFFICACY IN ADVANCED HEPATOCELLULAR CARCINOMA AMONG NON-CIRRHOTIC PATIENTS: FINDINGS FROM A RETROSPECTIVE MULTICENTER STUDY 2
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 2
Manuale di malattie infettive e microbiologia. SSM 2026 2
Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients 2
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers 2
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 2
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 2
Residual respiratory impairment after COVID-19 pneumonia 2
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab 2
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 2
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 2
Heparanase-1 and MMPs in Covid-19 and non-Covid-19 pneumonia 2
PO7-09-YI Does AtezoBev present as a safe and efficacious treatment option for hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicentric real-world study 2
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors 2
Can AtezoBev be a safe and effective option for treating hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicenter real-world study 2
OP034 LIVER DECOMPENSATION AS A NEW OUTCOME AND PROGNOSTIC INDICATOR IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB PLUS BEVACIZUMAB: A REAL-LIFE MULTICENTER STUDY 1
Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000–2015) 1
Neuropsychological measures of post-COVID-19 cognitive status 1
Totale 270
Categoria #
all - tutte 1.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026270 0 0 0 0 266 4 0 0 0 0 0 0
Totale 270